Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Ampyra 10mg beats 5mg, but weak overall results net neutral for ACOR
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
Assessing walking disability in multiple sclerosis.
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C.
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24weeks of therapy with subcutaneous interferon beta-1a three times weekly.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Immunopathology of multiple sclerosis.
Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Role of statins in the treatment of multiple sclerosis.
Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Direct angiotensin AT2-receptor stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Pages
« first
‹ previous
…
163
164
165
166
167
168
169
170
171
…
next ›
last »